CET

Clinical Trials Information System (CTIS): Walk-in clinic - March 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 March 2024, 16:00 (CET) to 12 March 2024, 17:00 (CET)

Retrieved on: 
Monday, December 18, 2023
FAQ, Location, CTIS, EMA, CET, Clinical trial, SME, Satellite navigation device, Pharmaceutical industry

The CTIS experts will address all the questions related to system functionalities.

Key Points: 
  • The CTIS experts will address all the questions related to system functionalities.
  • Questions about the interpretation of the Clinical Trial Regulation and /or national processes are out of the scope of this event.
  • The event is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations.
  • Please subscribe to the Clinical Trials Highlights newsletter for updates on the availability of CTIS event video recordings.

Clinical Trials Information System (CTIS): Walk-in clinic - January 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 January 2024, 16:00 (CET) to 24 January 2024, 17:00 (CET)

Retrieved on: 
Monday, December 18, 2023
Location, Clinical trial, PDF, FAQ, CTIS, EMA, CET, SME, Vimeo, Satellite navigation device, Pharmaceutical industry, Nightclub, Mobile phone, Broadcasting, Television

Questions about the interpretation of the Clinical Trial Regulation and /or national processes are out of the scope of this event.

Key Points: 
  • Questions about the interpretation of the Clinical Trial Regulation and /or national processes are out of the scope of this event.
  • The event is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations.
  • It will be a live broadcast; no registration is required for those wishing to follow the live broadcast on EMA’s website.
  • Please subscribe to the Clinical Trials Highlights newsletter for updates on the availability of CTIS event video recordings.

Clinical Trials Information System (CTIS): Walk-in clinic - November 2023, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 November 2023, 16:00 (CET) to 15 November 2023, 17:00 (CET)

Retrieved on: 
Monday, December 18, 2023
FAQ, Location, CTIS, EMA, CET, Clinical trial, SME, Satellite navigation device, Pharmaceutical industry

The CTIS experts will address all the questions related to system functionalities.

Key Points: 
  • The CTIS experts will address all the questions related to system functionalities.
  • Questions about the interpretation of the Clinical Trial Regulation and /or national processes are out of the scope of this event.
  • The event is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations.
  • Please subscribe to the Clinical Trials Highlights newsletter for updates on the availability of CTIS event video recordings.

Academia Info Day, European Medicines Agency, Amsterdam, the Netherlands, from 10 November 2023, 09:30 (CET) to 10 November 2023, 13:30 (CET)

Retrieved on: 
Monday, December 18, 2023
Academy, Public, Location, Student, European Medicines Agency, CET, Agency, RSS, Bookkeeping, Video game, Paraffin wax

Date

Key Points: 
  • Date
    - Friday, 10 November 2023, 09:30 (CET) - 13:30 (CET)
    Location
    - European Medicines Agency, Amsterdam, the Netherlands
    Event summary
    Event summary
    In line with the Agency efforts for transparency about how it works and comes to its decisions, the European Medicines Agency is launching this hybrid informative event conceived within the priorities of the Regulatory Science Strategy to 2025 (RSS 2025) and its Framework of collaboration between the European Medicines Agency and academia, with the vision to acquaint the Academic Sector, particularly students and young professionals, with regulatory standards and practice as well as the relevance of regulatory science for medicines innovation and public health.
  • Video recording
    Video recording
    Documents
    Contact point
    Contact point

ACT EU PA08 multi-stakeholder methodology workshop, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2023, 09:00 (CET) to 23 November 2023, 17:00 (CET)

Retrieved on: 
Monday, December 18, 2023
ACT, Trial, Clinical trial, Location, CET, Priority, European Medicines Agency, Flour, Medical device, Broadcasting, Music

This multi-stakeholder workshop on 23 November 2023 will offer participants the opportunity to:

Key Points: 
  • This multi-stakeholder workshop on 23 November 2023 will offer participants the opportunity to:
    • Understand different stakeholder perspectives on the development of clinical trial methodology guidance;
    • Discuss the status of guidance on priority clinical trial methodology topics;
    • Identify the need for new guidance or updates to the existing guidance for the priority methodology topics.
  • The output of the workshop will be brief scoping summaries for each methodology topic on the status and need for further guidance work, which will inform the future work of ACT EU Priority Action 8 and the EMRN.
  • No certificates of attendance will be issued for this workshop.
  • opening, reports from the breakout sessions, closing)
    - 10:00-12:00 Break-out session A: Complex trials I
    - 14:15-16:15 Break-out session E: Beyond RCTs
    Live broadcast: 0B
    - 10:00-12:00 Break-out session B: Paediatric Trials
    - 14:15-16:15 Break-out session F: Patient-centricity

Invitation to EQT's Capital Markets Day

Retrieved on: 
Monday, December 18, 2023
Lunch, EQT, Capital market, CET, Partner, Executive Committee

STOCKHOLM, Dec. 18, 2023 /PRNewswire/ -- A warm welcome to EQT's Capital Markets Day in Stockholm on Wednesday, 6 March 2024

Key Points: 
  • STOCKHOLM, Dec. 18, 2023 /PRNewswire/ -- A warm welcome to EQT's Capital Markets Day in Stockholm on Wednesday, 6 March 2024
    Since its inception nearly 30 years ago, EQT has grown to become a global leader in active ownership strategies.
  • At its Capital Market Day, EQT will reflect on the journey to date, look ahead to the future of private markets, and how EQT is continuously evolving its thematic investment strategy and distinctive value creation approach to create superior returns for its clients.
  • The event will be hosted by EQT's CEO Christian Sinding, EQT's Executive Committee, representatives from EQT's Partner group, and its Industrial Advisor Network.
  • The event will begin with registration and lunch at 12:00 pm CET and is hosted in person at Fotografiska Museet, Stockholm, Sweden.

CoinEx Celebrates Blockchain Innovation as Silver Sponsor at 2023 Taipei Blockchain Week and Offers Exclusive Rewards

Retrieved on: 
Thursday, December 14, 2023
Ice cream, Growth, CET, Silver, Ecosystem, Cryptocurrency

TAIPEI, Dec. 14, 2023 /PRNewswire/ -- CoinEx , a global cryptocurrency exchange renowned for its diverse trading services, is excited to announce its silver sponsorship of Taipei Blockchain Week, taking place from December 14th to 16th.

Key Points: 
  • TAIPEI, Dec. 14, 2023 /PRNewswire/ -- CoinEx , a global cryptocurrency exchange renowned for its diverse trading services, is excited to announce its silver sponsorship of Taipei Blockchain Week, taking place from December 14th to 16th.
  • Taipei Blockchain Week serves as a premier gathering for industry pioneers to share insights, explore new trends, and strengthen the community shaping decentralized technology's future.
  • As part of its strategy to encourage broader blockchain adoption and illustrate a commitment to the community, CoinEx views Taipei Blockchain Week as a prime setting for showcasing its user-centric philosophy.
  • CoinEx is eager to interact with attendees, share insights into its comprehensive crypto services, and demonstrate the platform's value at Taipei Blockchain Week.

CoinEx Celebrates Blockchain Innovation as Silver Sponsor at 2023 Taipei Blockchain Week and Offers Exclusive Rewards

Retrieved on: 
Thursday, December 14, 2023
Ice cream, Growth, CET, Silver, Ecosystem, Cryptocurrency

TAIPEI, Dec. 14, 2023 /PRNewswire/ -- CoinEx , a global cryptocurrency exchange renowned for its diverse trading services, is excited to announce its silver sponsorship of Taipei Blockchain Week, taking place from December 14th to 16th.

Key Points: 
  • TAIPEI, Dec. 14, 2023 /PRNewswire/ -- CoinEx , a global cryptocurrency exchange renowned for its diverse trading services, is excited to announce its silver sponsorship of Taipei Blockchain Week, taking place from December 14th to 16th.
  • Taipei Blockchain Week serves as a premier gathering for industry pioneers to share insights, explore new trends, and strengthen the community shaping decentralized technology's future.
  • As part of its strategy to encourage broader blockchain adoption and illustrate a commitment to the community, CoinEx views Taipei Blockchain Week as a prime setting for showcasing its user-centric philosophy.
  • CoinEx is eager to interact with attendees, share insights into its comprehensive crypto services, and demonstrate the platform's value at Taipei Blockchain Week.

LEQEMBI® to be launched in Japan for Alzheimer's disease on December 20

Retrieved on: 
Wednesday, December 13, 2023
Ministry of Health (Kuwait), Ministry, Brain, Risk management, Amyloid-related imaging abnormalities, Disease, Risk, History, Patient, CET, Intraparenchymal hemorrhage, Eisai, MCI, Alzheimer's disease, Marketing, Horseshoe kidney, Co-promotion, Ageing, ARIA, Hypersensitivity, NHI, HIV disease progression rates, Lecanemab, Medical device, Pharmaceutical industry, Residential care, Biogen, Health

LEQEMBI obtained manufacturing and marketing approval for the indication of slowing progression of mild cognitive impairment (MCI) and mild dementia due to Alzheimer's disease (AD) in Japan on September 25, 2023.

Key Points: 
  • LEQEMBI obtained manufacturing and marketing approval for the indication of slowing progression of mild cognitive impairment (MCI) and mild dementia due to Alzheimer's disease (AD) in Japan on September 25, 2023.
  • The launch, planned for December 20, will make Japan the second country to have the product on the market, following the U.S.
    "This is a great Christmas present!
  • Alzheimer's disease patients in Japan will now have access to the first disease modifying treatment.
  • This gives hope for the large aging population in Japan with a great need for new treatment options," says Gunilla Osswald, CEO of BioArctic.

LEQEMBI® to be launched in Japan for Alzheimer's disease on December 20

Retrieved on: 
Wednesday, December 13, 2023
Ministry of Health (Kuwait), Ministry, Brain, Risk management, Amyloid-related imaging abnormalities, Disease, Risk, History, Patient, CET, Intraparenchymal hemorrhage, Eisai, MCI, Alzheimer's disease, Marketing, Horseshoe kidney, Co-promotion, Ageing, ARIA, Hypersensitivity, NHI, HIV disease progression rates, Lecanemab, Medical device, Pharmaceutical industry, Residential care, Biogen, Health

LEQEMBI obtained manufacturing and marketing approval for the indication of slowing progression of mild cognitive impairment (MCI) and mild dementia due to Alzheimer's disease (AD) in Japan on September 25, 2023.

Key Points: 
  • LEQEMBI obtained manufacturing and marketing approval for the indication of slowing progression of mild cognitive impairment (MCI) and mild dementia due to Alzheimer's disease (AD) in Japan on September 25, 2023.
  • The launch, planned for December 20, will make Japan the second country to have the product on the market, following the U.S.
    "This is a great Christmas present!
  • Alzheimer's disease patients in Japan will now have access to the first disease modifying treatment.
  • This gives hope for the large aging population in Japan with a great need for new treatment options," says Gunilla Osswald, CEO of BioArctic.